Compare Cassava Sciences Inc (FLNA) vs Unilever plc (UL) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Unilever (UL) trades at $62.49, up 2.71% with a bullish technical signal. Recent earnings misses contrast with strong profitability margins and a 53.32% ROE. The company is divesting its food business to McCormick and investing in innovation, while maintaining a $0.54 dividend. Cash flow improved to $1.91B net in 2024 after a volatile period.

Outlook remains mixed: valuation appears fair with a P/E of 20.83, but revenue declines and execution risks on strategic deals pose challenges. Analyst sentiment is cautious with only 24% buy ratings. The stock offers stability through dividends but faces headwinds in sales growth and competitive pressures.